figshare
Browse
cb3001952_si_001.pdf (1.38 MB)

Discovery of γ-Secretase Modulators with a Novel Activity Profile by Text-Based Virtual Screening

Download (1.38 MB)
journal contribution
posted on 2012-09-21, 00:00 authored by Heiko Zettl, Julia Ness, Volker Hähnke, Dirk Beher, Thorsten Jumpertz, Arman Saric, Karlheinz Baumann, Claus U. Pietrzik, Bruno Bulic, Gisbert Schneider, Sascha Weggen
We present an integrated approach to identify and optimize a novel class of γ-secretase modulators (GSMs) with a unique pharmacological profile. Our strategy included (i) virtual screening through application of a recently developed protocol (PhAST), (ii) synthetic chemistry to discover structure–activity relationships, and (iii) detailed in vitro pharmacological characterization. GSMs are promising agents for treatment or prevention of Alzheimer’s disease. They modulate the γ-secretase product spectrum (i.e., amyloid-β (Aβ) peptides of different length) and induce a shift from toxic Aβ42 to shorter Aβ species such as Aβ38 with no or minimal effect on the overall rate of γ-secretase cleavage. We describe the identification of a series of 4-hydroxypyridin-2-one derivatives, which display a novel type of γ-secretase modulation with equipotent inhibition of Aβ42 and Aβ38 peptide species.

History

Usage metrics

    ACS Chemical Biology

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC